- Home
- MNKD vs NVTS Comparison
MNKD vs NVTS Comparison
Compare MNKD & NVTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNKD
- NVTS
- Stock Information
- Founded
- MNKD 1991
- NVTS 2014
- Country
- MNKD United States
- NVTS United States
- Employees
- MNKD N/A
- NVTS N/A
- Industry
- MNKD Biotechnology: Pharmaceutical Preparations
- NVTS Semiconductors
- Sector
- MNKD Health Care
- NVTS Technology
- Exchange
- MNKD Nasdaq
- NVTS Nasdaq
- Market Cap
- MNKD 1.4B
- NVTS 1.3B
- IPO Year
- MNKD 2004
- NVTS N/A
- Fundamental
- Price
- MNKD $3.69
- NVTS $6.38
- Analyst Decision
- MNKD Buy
- NVTS Strong Buy
- Analyst Count
- MNKD 4
- NVTS 6
- Target Price
- MNKD $9.75
- NVTS $3.79
- AVG Volume (30 Days)
- MNKD 3.2M
- NVTS 59.4M
- Earning Date
- MNKD 08-06-2025
- NVTS 08-04-2025
- Dividend Yield
- MNKD N/A
- NVTS N/A
- EPS Growth
- MNKD 228.27
- NVTS N/A
- EPS
- MNKD 0.10
- NVTS N/A
- Revenue
- MNKD $297,595,000.00
- NVTS $74,145,000.00
- Revenue This Year
- MNKD $13.72
- NVTS N/A
- Revenue Next Year
- MNKD $15.21
- NVTS $51.14
- P/E Ratio
- MNKD $35.96
- NVTS N/A
- Revenue Growth
- MNKD 32.50
- NVTS N/A
- 52 Week Low
- MNKD $3.63
- NVTS $1.52
- 52 Week High
- MNKD $7.63
- NVTS $9.17
- Technical
- Relative Strength Index (RSI)
- MNKD 35.30
- NVTS 52.45
- Support Level
- MNKD $3.65
- NVTS $6.31
- Resistance Level
- MNKD $4.00
- NVTS $7.99
- Average True Range (ATR)
- MNKD 0.15
- NVTS 0.69
- MACD
- MNKD 0.00
- NVTS -0.26
- Stochastic Oscillator
- MNKD 12.16
- NVTS 5.26
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About NVTS Navitas Semiconductor Corporation
Navitas Semiconductor Corp develops ultra-efficient gallium nitride (GaN) semiconductors that are revolutionizing power electronics. GaN power ICs integrate GaN power with drive, control, and protection to enable fast charging, high power density, and energy savings for mobile, consumer, enterprise, eMobility, and new energy markets. The company operates as one reportable segment, the design, development, manufacture, and marketing of integrated circuits and related components for use in mobile device and other markets. Geographically, the company operates in China, Europe, United States, Rest of Asia and Others. The majority of revenue is generated from China.